You just read:

PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

News provided by

Cell Therapeutics, Inc.

Apr 29, 2014, 01:30 ET